Загрузка...
Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight
The pandemic of SARS-CoV-2 has necessitated expedited research efforts towards finding potential antiviral targets and drug development measures. While new drug discovery is time consuming, drug repurposing has been a promising area for elaborate virtual screening and identification of existing FDA...
Сохранить в:
| Опубликовано в: : | Biochem Biophys Res Commun |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8282484/ https://ncbi.nlm.nih.gov/pubmed/34303192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2021.07.050 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|